Statistics

Total Visits

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The44

Select a period of time:

Number of views in the range

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The15

Views

Views
November 20250
December 20251
January 20264
February 20260
March 20262
April 20260
May 20268
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Argentina1
China1
Germany1
Spain1
France1
Sweden1
Senegal1
South Africa1
 

Top cities views

Views
Dakar1
Frankfurt am Main1
Helsingborg1
Los Angeles1
Lyon1
Malmesbury1
Plasencia1
Resistencia1